Overview
Sumatriptan is a medication belonging to the triptan class, specifically designed to treat acute migraine and cluster headaches. It was first approved by the FDA in 1992 and has since become a cornerstone in migraine therapy. The drug works by selectively activating serotonin 5-HT1B/1D receptors, leading to vasoconstriction of dilated cranial blood vessels and inhibition of pro-inflammatory neuropeptide release. As a small molecule drug, sumatriptan is available in multiple formulations, including oral tablets, nasal sprays, subcutaneous injections, and suppositories. Each formulation offers different onset times and bioavailability, allowing healthcare providers to tailor treatment based on patient needs and headache severity.
Physical and Chemical Properties
Sumatriptan is a white to off-white crystalline powder with a molecular weight of 295.4 g/mol. Its molecular formula is C14H21N3O2S, featuring a sulfonamide group and an indole ring structure that contribute to its receptor-binding affinity. The compound melts at approximately 168-170°C and demonstrates good solubility in water and ethanol, facilitating its formulation into various pharmaceutical delivery systems. The drug exhibits stability under recommended storage conditions (2-8°C, protected from light) but may degrade when exposed to heat, moisture, or strong oxidizing agents. Its pKa values of 9.6 (basic) and -1.8 (acidic) influence its ionization state across physiological pH ranges, affecting its absorption and distribution characteristics.
Main Applications
Sumatriptan's primary application is the acute treatment of migraine attacks with or without aura in adults. Clinical studies demonstrate its effectiveness in relieving headache pain, photophobia, phonophobia, and nausea within 2 hours for most patients when administered at the onset of symptoms. The subcutaneous formulation (6 mg dose) shows the fastest onset, often providing relief within 10-15 minutes, making it particularly valuable for severe attacks. In addition to migraines, sumatriptan is used off-label for cluster headaches, a condition characterized by excruciating unilateral pain. Some clinicians also prescribe it for refractory cases of tension-type headaches, though this use lacks robust FDA approval. The drug is typically not used for headache prevention due to its mechanism targeting acute symptoms rather than underlying causes.
Safety and Storage
Sumatriptan carries several important safety considerations. Due to its vasoconstrictive properties, it is contraindicated in patients with ischemic heart disease, uncontrolled hypertension, or cerebrovascular syndromes. Common side effects include tingling sensations, flushing, dizziness, and injection site reactions (for subcutaneous forms). Rare but serious adverse events include coronary artery vasospasm and serotonin syndrome when combined with other serotonergic drugs. Proper storage is essential to maintain sumatriptan's stability. Bulk pharmaceutical material should be kept in tightly sealed containers under refrigerated conditions (2-8°C) with desiccant packs to prevent moisture absorption. Finished products have varying storage requirements depending on formulation - for example, injection kits may tolerate room temperature for short periods while maintaining sterility.
B2B Procurement Guide
When procuring sumatriptan in bulk for pharmaceutical manufacturing, buyers should prioritize suppliers with documented Good Manufacturing Practice (GMP) compliance and active Drug Master Files (DMFs) with regulatory agencies. Key quality parameters to verify include purity (typically ≥98% by HPLC), residual solvent levels, and absence of specified impurities per ICH guidelines. Purchase agreements should specify batch testing requirements, including identity confirmation by FTIR or NMR, assay validation, and microbial limits testing where applicable. Given sumatriptan's temperature sensitivity, logistics planning must ensure cold chain maintenance during transportation. For reference, pharmaceutical-grade sumatriptan base typically trades in the range of $50-$200 per gram depending on quantity and supplier qualifications, with significant price variations for different salt forms (e.g., succinate).
Related Manufacturers
- 主营：sumatriptan、白蜡树素、百两金素、半齿泽兰素
- 主营：实验试剂、工具化合物、抗体抑制剂、重组蛋白
- 主营：抑制剂、化合物库、药物筛选、天然产物